HCG Nagpur Introduces Scalp Cooling for Cancer Patients

HCG Cancer Center Nagpur brought out a state-of-the-art and first-of-its-kind modern scalp-cooling therapy in Asia for patients diagnosed with cancer and being treated with chemotherapy.

This therapy prevents alopecia (hair loss) and other obstructions caused by chemotherapy, as well as ensures fast hair regrowth after completion of the treatment. Medical oncologists, including Dr. Sushant Ikhar, Dr. Shantanu Pendse, and Dr. Kapil Raut, unveiled this technology.

EVA is the latest and most advanced cap cooling equipment (Smart Temperature Management), not just because it is cheaper to maintain but also because it takes pride in keeping patients' physical and mental beauty after chemotherapy treatment.

A scalp cooling device is a machine placed on patients' heads during chemotherapy. It helps maintain the scalp temperature lower than other body temperatures to reduce the chemo effect on hair follicles. During this trial, a precisely formed cooler cap is covered around the patient's head, which guards the temperature during the monitored chemo infusion.

Mr. Venkateshwarlu Marapaka, the Chief Operating Officer of HCG Cancer Centre at Nagpur, remarked that “this outstanding scalp cooling therapy is the first of its kind for breast cancer patients in Asia.” This treatment will become a guiding star, and all our patients will hold on to it despite the hardships.

The arrival in the clinic of the scalp cooling devices created this faint hope for cancer patients who had suffered hair loss because of chemotherapy before. The cancer helpline (HCG) has a stubborn and persistent goal, which is the improvement of the outlook of the patients who have cancer. It was enough said.

Several factors emphasized the efficacy of scalp cooling therapy, such as the type and stage of cancer, the type and dose of chemo, the patient's hair type, and overall health.